Thermo Fisher Scientific Inc. (NYSE: TMO) had its "buy" rating re-affirmed by analysts at Credit Suisse Group AG. They now have a $310.00 price target on the stock.
Last thermo fisher scientific, inc earnings: 4/22 06:00 am
Check Earnings Report
US:NYSE Investor Relations: ir.thermofisher.com/investors/investor-overview/default.aspx
Impact snapshot | Event time: | TMO | ||||
---|---|---|---|---|---|---|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last price | ||
VWAP | ||
High:
|
Max up |
High:
|
Low:
|
Max down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event Day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance Since Event
Time and Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
SIGN UP TODAY
Opt-in for
TMO alerts
TMO alerts
from News Quantified
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TMO alerts
High impacting Thermo Fisher Scientific, Inc news events
Weekly update
A roundup of the hottest topics
TMO
News
- UPDATE 2-Thermo Fisher buys Henogen for nearly $880 mln in gene therapy expansion [Reuters]Reuters
- Thermo Fisher buys viral vector manufacturing business from Novasep for ~ €725M [Seeking Alpha]Seeking Alpha
- UPDATE 1-Thermo Fisher buys Henogen for nearly $880 mln in gene therapy expansion [Reuters]Reuters
- Thermo Fisher buys Henogen for nearly $880 million in gene therapy expansion [Reuters]Reuters
- REFILE-Thermo Fisher buys Belgium's Henogen for nearly $880 mln [Reuters]Reuters
- More
TMO
SEC Filings
- 1/15/21 - Form 25-NSE
- 1/11/21 - Form 8-K
- 1/5/21 - Form 4
- TMO's page on the SEC website
- More